AJP - Heart Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 274: H743-H746, 1998;
0363-6135/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schipke, J. D.
Right arrow Articles by Arnold, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schipke, J. D.
Right arrow Articles by Arnold, G.
Vol. 274, Issue 3, H743-H746, March 1998

Basal metabolism does not account for high O2 consumption in stunned myocardium

J. D. Schipke1, B. Korbmacher2, U. Schwanke1, D. Frehen2, T. Schmidt1, and G. Arnold1

1 Institute of Experimental Surgery and 2 Clinic of Thoracic and Cardiovascular Surgery, Heinrich-Heine-University Düsseldorf, D-40225 Düsseldorf, Germany

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Myocardial O2 consumption (MVO2) in stunned myocardium is relatively high compared with the reduced ventricular function. The mechanism of this "oxygen paradox" could occur at different levels: basal metabolism, excitation-contraction coupling, and energy production. In one previously reported series on 12 isolated, blood-perfused rabbit hearts, left ventricular systolic and diastolic function in stunned myocardium were significantly decreased compared with control, whereas total MVO2 was not. The MVO2 for the unloaded contraction was overproportionately high for the decreased function in stunned myocardium, and contractile efficiency was clearly deteriorated. To assess whether the basal metabolism specifically is elevated in stunned myocardium, a second series (n =14) with a similar protocol was performed in this study. Basal MVO2 after KCl arrest (0.5 ± 0.3 ml · min-1 · 100 g-1) was significantly lower than that measured after KCl arrest (1.2 ± 0.5 ml · min-1 · 100 g-1) in an additional series on nonischemic hearts (n = 8). Our conclusion is that basal MVO2 in stunned myocardium is not elevated. Thus this O2-consuming portion of total MVO2 is not responsible for the inefficiency in stunned myocardium. Instead, a "metabolic stunning" occurs at the level of both excitation-contraction coupling and force development by the contractile apparatus.

myocardial stunning; isolated heart; rabbit

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

DESPITE THE ABUNDANCE of literature on myocardial stunning (2, 10, 24, 27), the phenomenon remains poorly understood. Although ventricular function is substantially depressed, O2 consumption (VO2) in the stunned myocardium is normal or close to normal (1, 16, 18). Hence, the stunned myocardium is inefficient (1, 16, 26). The reason for this inefficiency could be due to high myocardial VO2 (MVO2) for excitation-contraction coupling (16), uncoupling between substrate metabolism and energy production, accelerated but useless energy drainage (19), some impairment between energy transfer and function of contractile proteins (6, 19), or increased ATP requirements for force generation by the myofilaments (5). The relatively high MVO2 has also been attributed to repair processes taking place in the stunned myocardium (2, 8).

In a previous study (28), we showed that the VO2 for the unloaded contraction was not decreased in stunned myocardium. In that study, however, we did not differentiate between the basal VO2 and the MVO2 for excitation-contraction coupling. To assess whether the basal metabolism is disturbed in the stunned myocardium, we performed experiments on isolated, blood-perfused rabbit hearts, and hemodynamic variables and VO2 were assessed during control, in postischemic, reperfused myocardium, and during subsequent cardiac arrest after KCl administration. For comparison, basal VO2 was assessed in normal hearts both during control and after KCl administration.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Experimental preparation. Experiments were performed on a total of 22 male New Zealand White rabbits with an average age of 6 mo and an average body mass of 3,500 ± 850 g; the rabbits were handled according to the animal welfare regulations of the German federal authorities. The hearts were connected to a modified Langendorff apparatus after rapid excision and were continuously perfused at normothermia.

Bovine erythrocytes were added to the modified Krebs-Henseleit solution (11 mM glucose) so that the hemoglobin concentration was equal to 10.3 ± 0.3 g/100 ml blood. The solution contained 4 g/100 ml albumin, and the concentration of free Ca2+ was adjusted to 2.5 mM. The recirculating erythrocyte suspension was oxygenated using a pediatric hollow fiber oxygenator (Masterflo 34, Dideco). The gas mixture contained 72% N2-22% O2-6% CO2. The perfusate temperature was held at 38°C, and the coronary arterial pressure was controlled using a servo-controlled roller pump (505L, Watson Marlow).

A water-filled latex balloon (no. 12-14, H. Sachs Elektronik) was inserted into the left ventricular (LV) cavity through the mitral valve. The balloon was connected to a "systemic" circuit that contained two artificial valves and a windkessel. An ultrasonic flow probe in connection with a flowmeter (T-206, Transonic Systems) was used to assess aortic flow, and a pressure transducer (P23 XL, Statham) was used to measure aortic pressure as an index of LV afterload. This circuit permitted independent changes in preload and afterload conditions. A 3-F microtip manometer (TC-500, Millar) was inserted into the balloon to measure LV pressure. For measurement of left intraventricular diameter, sonomicrometry was employed (System 6, Triton) with the use of piezoelectric crystals that were glued to either side of the balloon. Blood from the right heart was drained via a cannula placed in the pulmonary artery to measure total coronary blood flow (CBF) using another ultrasonic flow probe. The difference in arteriovenous O2 content (a-vO2) was continuously measured using absorption spectrophotometry (AVOX systems; Ref. 29). This system was independently calibrated using measurements provided by a Lex-O2-Con analyzer.

Experimental protocol. After the experimental instrumentation was completed and the ventricular function was stabilized, control measurements were made. In a nonischemic control series (n = 8), 5 ml KCl, corresponding to a final concentration of 20 mM, were injected into the arterial line to induce cardiac arrest. CBF and a-vO2 were measured 5 min after KCl arrest. In a second series (n = 14), the hearts were subjected to a period of 20 min of normothermic, no-flow ischemia. Thirty minutes after the onset of reperfusion, data were again recorded. The same KCl dose was then injected, and CBF and a-vO2 were measured 5 min thereafter. During control and reperfusion, coronary arterial pressure was held constant (80 ± 2 mmHg). All variables were assessed at a constant temperature of 38°C maintained by immersing the hearts in a temperature-controlled chamber filled with venous blood. LV preload, estimated using intraventricular diameter, was maintained constant as well. The hearts were weighed at the end of the protocol.

Data acquisition. The following variables were continuously recorded with an eight-channel, forced-ink chart recorder (type 481, Brush): aortic flow, LV pressure, first derivative of pressure over time (dP/dt), intraventricular diameter, CBF, and a-vO2. To exclude afterload-dependent changes, peak systolic pressure and maximum and minimum dP/dt (dP/dtmax and dP/dtmin) were recorded while the outflow tract was temporarily cross clamped. The data were simultaneously stored on magnetic disk after digitization at a sampling rate of 300 Hz for later analysis using a custom-made computer program (EASYDAT; Ref. 4).

Calculations and statistics. Hemodynamic data were analyzed via the same computer program (EASYDAT; Ref. 4). Heart rate, dP/dtmax, and dP/dtmin were derived from the LV pressure signal. CBF was normalized to 100 g wet wt. MVO2 was calculated according to the Fick principle from the normalized CBF and the a-vO2.

Data are presented as means ± SD. Statistical analysis was performed with an IBM-compatible personal computer and a statistical software package (SYSTAT; Ref. 37). Nonischemic data were compared with the use of one-way analysis of variance. A P value < 0.05 was considered indicative of a significant difference.

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Control series. Control heart rate was 163 ± 30 beats/min, aortic flow was 39 ± 18 ml/min, maximum isovolumic LV pressure (LVPmax) was 112 ± 36 mmHg, and dP/dtmax was 1,260 ± 410 mmHg/s. Early LV relaxation, assessed using dP/dtmin, was -1,215 ± 520 mmHg/s. CBF was 99 ± 33 ml · min-1 · 100 g-1, and a-vO2 was 7.4 ± 1.6 ml/100 ml. Thus MVO2 was equal to 7.0 ± 1.8 ml · min-1 · 100 g-1.

After KCl arrest, CBF decreased to 19 ± 17 ml · min-1 · 100 g-1, whereas the a-vO2 increased to 9.6 ± 3.8 ml/100 ml. MVO2 was 1.2 ± 0.5 ml · min-1 · 100 g-1.

Postischemic reperfused hearts. During control, heart rate was 137 ± 23 beats/min, aortic flow was 40 ± 14 ml/min, isovolumic LVPmax was 120 ± 18 mmHg, and dP/dtmax was 1,175 ± 270 mmHg/s. Early relaxation, assessed using dP/dtmin, was -980 ± 255 mmHg/s. CBF was 78 ± 28 ml · min-1 · 100 g-1, and total MVO2 was 5.3 ± 1.1 ml · min-1 · 100 g-1.

Heart rate in the postischemic reperfused hearts was 126 ± 25 beats/min (not significant), and aortic flow was 4 ± 4 ml/min. LVPmax (66 ± 9 mmHg), dP/dtmax (545 ± 265 mmHg/s), and early relaxation (dP/dtmin; 440 ± 246 mmHg/s) were significantly impaired. In parallel with these functional changes, CBF decreased to 61 ± 27 ml · min-1 · 100 g-1, and MVO2 decreased to 3.4 ± 3.3 ml · min-1 · 100 g-1.

After subsequent KCl arrest, CBF decreased to 14 ± 5 ml · min-1 · 100 g-1, and MVO2 was 0.5 ± 0.3 ml · min-1 · 100 g-1.

In hearts from a previous series (28), the variables during control were comparable with the variables from the present study, and they were similarly changed at 30 min of reperfusion after 20 min of global ischemia. In that series, the linear relationship between the pressure-volume area (PVA) and the total MVO2, which provides both the contractile efficiency (inverse slope) and the MVO2 for the unloaded contraction (MVO2 axis intercept), was assessed. The contractile efficiency significantly decreased (31 ± 18 vs. 14 ± 7%), whereas MVO2 for the unloaded contraction did not (3.8 ± 1.3 vs. 3.4 ± 0.9 ml · min-1 · 100 g-1).

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The main finding of the present study on isolated, blood-perfused rabbit hearts is that the basal metabolism is not elevated in stunned myocardium compared with that in nonischemic myocardium. Thus this fraction of MVO2 does not account for the inappropriately high VO2 compared with the impaired systolic and diastolic contractile function.

Ventricular function. The decreased global measures in both our previous (28) and present studies on isolated hearts are in concert with results from in situ investigations that had already shown impaired systolic (9, 25, 33) and diastolic (7, 11, 36) function in the postischemic reperfused myocardium.

Total MVO2 in stunned myocardium. Possible causes that have been suggested for the contractile dysfunction persisting despite normal MVO2 include uncoupling between substrate metabolism and energy production, accelerated but useless energy drainage (19), or some impairment between energy transfer and the function of contractile proteins (6, 19). In addition, increased ATP requirements for force generation by the myofilaments were suggested to be responsible for inadequate MVO2 (5). In a previous study (28), stroke work was decreased by as much as 80%, whereas total MVO2 was decreased by only ~16%. Thus the ratio between stroke work and MVO2 (index of external efficiency) was drastically reduced in the postischemic myocardium, showing that the postischemic myocardium is energetically inefficient (1, 5, 16, 26).

Such conditions might become important clinically if function in the stunned myocardium is augmented after inotropes or during exercise, because the additionally supplied O2 during positive inotropic stimulation will only inefficiently be converted into energy, such that ischemia can likely be induced again.

MVO2 for the unloaded contraction. The MVO2 for the unloaded contraction was obtained via extrapolation of the linear relationship between total MVO2 and the PVA. This framework allows separate analysis of the MVO2 that is associated with ventricular work (PVA dependent = excess MVO2) and MVO2 that is non-work related (MVO2 for the unloaded contraction; Ref. 32). In a previous study (28), it was shown that the MVO2 for the unloaded contraction was not decreased in the stunned myocardium. Similar results were obtained in a study (23) on isolated, blood-perfused canine hearts. The MVO2 for the unloaded contraction increases with increasing contractile state (32) and decreases with decreasing contractile state (31). With respect to the depressed contractile state in the stunned myocardium, this MVO2 fraction was inadequately high.

Contractile efficiency. The linear relationship between MVO2 and the PVA describes the contractile efficiency (32), i.e., the relationship between the contraction and the O2 needed for that contraction (30). Contractile efficiency for the stunned myocardium was clearly decreased in our previous study (28), suggesting an abnormality in the contractile process (16) or some impairment between energy transfer and function of contractile proteins (19). This result is in contrast, however, with the increased contractile efficiency reported from cross-circulated, isolated canine hearts (23), a finding that might be explained with different MVO2 levels during control (4.5 ml · min-1 · 100 g-1 in canine hearts vs. 5.7 ml · min-1 · 100 g-1 in rabbit hearts) or that might be attributed to species-dependent differences.

MVO2 in the arrested heart. The MVO2 for the unloaded contraction includes one fraction for basal myocardial metabolism and another for excitation-contraction coupling. To determine which of the two fractions had changed, the basal MVO2 was assessed in this study after cardiac arrest. Basal MVO2 averaged 0.5 ± 0.3 ml · min-1 · 100 g-1, which is significantly lower than that in the nonischemic, arrested hearts (1.2 ± 0.5 ml · min-1 · 100 g-1). In cross-circulated, isolated canine hearts (23), the basal MVO2 in postischemic hearts was also lower compared with that in control hearts. That this apparent difference was not statistically significant might be explained with the lower MVO2 levels during control in that study (4.5 vs. 5.7 ml · min-1 · 100 g-1). On the other hand, we cannot exclude species-dependent differences.

Basal MVO2 in nonischemic, arrested hearts from different species varies from ~2.0 to 3.5 ml · min-1 · 100 g-1 (17, 20, 22, 34, 35). In contrast, values can be as low as 1.0 ml · min-1 · 100 g-1 (12, 16, 21, 23, 35). So far, the lowest basal MVO2 values reported from nonischemic hearts before arrest are equal to 0.6 (3) and 0.7 ml · min-1 · 100 g-1 (13). These three different levels suggest that it is difficult to define and measure basal MVO2. Obviously, the values depend on several factors such as time of measurement after cardiac arrest, perfusion pressure, temperature, and type of arrest (20), conditions that were comparable for the three series reported in this study.

In summary, the basal MVO2 in stunned hearts is lower compared with prestunning levels. Therefore, the relatively high MVO2 in stunned myocardium cannot be explained by repair processes taking place during that condition (2, 8). This notion would be in concord with a previous study on isolated rabbit hearts that were buffer perfused (16) and with a study on excised, cross-circulated anine hearts that focused on the increased O2 cost of contractility in the stunned myocardium (23).

The maintained MVO2 for the unloaded contraction suggests that the fraction of MVO2 attributable to excitation-contraction coupling is disproportionately high in stunned myocardium and, in fact, impairment of Ca2+ handling has frequently been held to be responsible (14-16, 24). The reduced contractile efficiency, in addition, is indicative of an impaired O2 utilization by the contractile apparatus. We suggest that, besides the functional, vascular, and electrical stunning, a "metabolic stunning" exists.

    ACKNOWLEDGEMENTS

The study was partly supported by the Deutsche Forschungsgemeinschaft (SFB 242:C7, Coronary Heart Disease, Düsseldorf, Germany). We greatly appreciate reading and correcting of the manuscript by N. Palomero-Gallagher. We thank D. Schäfer for excellent technical support.

    FOOTNOTES

Address for reprint requests: J. D. Schipke, Institut für Experimentelle Chirurgie, Heinrich-Heine-Universität Düsseldorf, Universitätsstr. 1, D-40225 Düsseldorf, Germany.

Received 23 May 1997; accepted in final form 17 October 1997.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1.   Allen, B. S., E. P. Rosenkranz, G. D. Buckberg, J. Vinten-Johansen, F. Okamoto, and J. Leaf. Studies of controlled reperfusion after ischemia. VII. High oxygen requirements of dyskinetic cardiac muscle. J. Thorac. Cardiovasc. Surg. 92: 543-552, 1986[Abstract].

2.   Bolli, R. Myocardial "stunning" in man. Circulation 86: 1671-1691, 1992[Free Full Text].

3.   Bonhoeffer, K. Der Sauerstoffverbrauch des normo- und hypothermen Hundeherzens vor und während verschiedener Formen des induzierten Herzstillstandes. Basel: Karger, 1967.

4.   Brieden, A., U. Schwanke, G. Arnold, and J. D. Schipke. A computer program to acquire and process data from the experimental laboratory (Abstract). Pflügers Arch. 433: P-410, 1997.

5.   Burkhoff, D. Myocardial energetics and the postischemic heart. Ann. Thorac. Surg. 49: 525-527, 1990[Medline].

6.   Burkhoff, D., P. P. de Tombe, W. C. Hunter, and D. A. Kass. Contractile strength and mechanical efficiency of left ventricle are enhanced by physiological afterload. Am. J. Physiol. 260 (Heart Circ. Physiol. 29): H569-H578, 1991[Abstract/Free Full Text].

7.   Ehring, T., R. Schulz, J. D. Schipke, and G. Heusch. Diastolic dysfunction of stunned myocardium. Am. J. Cardiovasc. Pathol. 4: 358-366, 1993[Medline].

8.   Furukawa, S., J. E. Bavaria, G. Kreiner, and L. H. Edmunds, Jr. Relationship between total mechanical energy and oxygen consumption in the stunned myocardium. Ann. Thorac. Surg. 49: 543-549, 1990[Abstract].

9.   Glower, D. D., J. Schaper, J. S. Kapas, H. M. Hoffmeister, W. Schaper, J. A. Spratt, J. W. Davis, and J. S. Rankin. Relation between reversal of diastolic creep and recovery of systolic function after ischemic myocardial injury in conscious dogs. Circ. Res. 60: 850-860, 1987[Abstract/Free Full Text].

10.   Hearse, D. J. Stunning: a radical re-view. Cardiovasc. Drugs Ther. 5: 853-876, 1991[Medline].

11.  Heyndrickx, G. R., W. J. Paulus, P. Vantrimpont, and D. Vogelaers. Left ventricular diastolic stunning coincides with regional systolic asynchrony between normal and stunned myocardium (Abstract). Circulation 80, Suppl. II: II-97, 1989.

12.   Hoffmeister, H. E., H. Kreuzer, and W. Schoeppe. Der Sauerstoffverbrauch des stillstehenden, des leerschlagenden und des flimmernden Herzens. Pflügers Arch. 269: 194-198, 1959.

13.   Korb, H., A. Hoeft, D. Baller, H. G. Wolpers, G. Hellige, and H. J. Bretschneider. Quantification of ischemic stress during repeated coronary artery occlusion in the dog. A method for validation of therapeutic effects. II. Reproducibility of release and uptake of electrolytes and substrates. Basic Res. Cardiol. 79: 38-48, 1984[Medline].

14.   Krause, S. M., W. E. Jacobus, and L. C. Becker. Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic "stunned" myocardium. Circ. Res. 65: 526-530, 1989[Abstract/Free Full Text].

15.   Kusuoka, H., and E. Marban. Cellular mechanisms of myocardial stunning. Annu. Rev. Physiol. 54: 243-256, 1992[Medline].

16.   Laster, S. B., L. C. Becker, G. Ambrosio, and W. E. Jacobus. Reduced aerobic metabolic efficiency in globally "stunned" myocardium. J. Mol. Cell. Cardiol. 21: 419-426, 1989[Medline].

17.   Laurent, D., C. Bolene-Williams, F. L. Williams, and L. N. Katz. Effects of heart rate on coronary flow and cardiac oxygen consumption. Am. J. Physiol. 185: 355-358, 1956.

18.   Laxson, D. D., D. C. Homans, X.-Z. Dai, E. Sublett, and R. J. Bache. Oxygen consumption and coronary reactivity in postischemic myocardium. Circ. Res. 64: 9-20, 1989[Abstract/Free Full Text].

19.   Liedtke, A. J., L. De Maison, A. M. Eggleston, L. M. Cohen, and S. A. Nellis. Changes in substrate metabolism and effects of excess fatty acids in reperfused myocardium. Circ. Res. 62: 535-542, 1988[Abstract/Free Full Text].

20.   Lochner, W., G. Arnold, and E. R. Müller-Ruchholtz. Metabolism in the artificially arrested heart and of the gas-perfused heart. Am. J. Cardiol. 22: 299-311, 1968[Medline].

21.   Lochner, W., and R. Dudziak. Stillstandumsatz und Ruheumsatz des Herzens. Pflügers Arch. 285: 169-174, 1965.

22.   McKeever, W. P., D. E. Gregg, and P. E. Canney. Oxygen uptake of the non-working left ventricle. Circ. Res. 6: 612-618, 1958[Abstract/Free Full Text].

23.   Ohgoshi, Y., Y. Goto, S. Futaki, H. Yaku, O. Kawaguchi, and H. Suga. Increased oxygen cost of contractility in stunned myocardium of dog. Circ. Res. 69: 975-988, 1991[Abstract/Free Full Text].

24.   Opie, L. H. Postischemic stunning: the case for calcium as the ultimate culprit. Cardiovasc. Drugs Ther. 5: 895-900, 1991[Medline].

25.   Preuss, K. C., G. J. Gross, H. L. Brooks, and D. C. Warltier. Time course of recovery of "stunned" myocardium following variable periods of ischemia in conscious and anesthetized dogs. Am. Heart J. 114: 696-703, 1987[Medline].

26.   Sako, E. Y., P. B. Kingsley-Hickmann, A. H. L. From, J. E. Foker, and K. Ugurbil. ATP synthesis kinetics and mitochondrial function in the postischemic myocardium as studied by 31P NMR. J. Biol. Chem. 263: 10600-10607, 1988[Abstract/Free Full Text].

27.   Schipke, J. D., B. Korbmacher, A. Dorczewski, G. Selcan, U. Sunderdiek, and G. Arnold. Hemodynamic and energetic properties of stunned myocardium in rabbit hearts. Heart 75: 55-61, 1996.[Abstract/Free Full Text]

28.   Schipke, J. D., U. Sunderdiek, B. Korbmacher, U. Schwanke, and G. Arnold. Utilization of oxygen by the contractile apparatus is disturbed during reperfusion of post-ischemic myocardium. Eur. Heart J. 16: 1476-1481, 1995[Abstract/Free Full Text].

29.   Shepherd, A. P., and C. G. Burgar. A solid-state arteriovenous oxygen difference analyzer for flowing whole blood. Am. J. Physiol. 232 (Heart Circ. Physiol. 1): H437-H440, 1977[Abstract/Free Full Text].

30.   Suga, H. Ventricular energetics. Physiol. Rev. 70: 247-277, 1990[Free Full Text].

31.   Suga, H., Y. Goto, Y. Yasamura, T. Nozawa, S. Futaki, N. Tanaka, and M. Uenishi. O2 consumption of dog heart under decreased coronary perfusion and propranolol. Am. J. Physiol. 254 (Heart Circ. Physiol. 23): H292-H303, 1988[Abstract/Free Full Text].

32.   Suga, H., R. Hisano, Y. Goto, O. Yamada, and Y. Igarashi. Effect of positive inotropic agents on the relation between oxygen consumption and systolic pressure-volume area in canine left ventricle. Circ. Res. 53: 306-318, 1983[Abstract/Free Full Text].

33.   Triana, J. F., X.-Y. Li, U. Jamaluddin, J. I. Thornby, and R. Bolli. Postischemic myocardial "stunning" identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious dog. Circ. Res. 69: 731-747, 1991[Abstract/Free Full Text].

34.   Van Citters, R. L., W. E. Ruth, and K. R. Reisman. Effect of heart rate on oxygen consumption of isolated dog heart performing no external work. Am. J. Physiol. 191: 443-448, 1957.

35.   Whalen, W. J. Some factors influencing O2 consumption of isolated heart muscle. Am. J. Physiol. 198: 1153-1159, 1960.

36.   Wijns, W., P. W. Serruys, C. J. Slager, J. Grimm, H. P. Krayenbuehl, P. G. Hugenholtz, and O. M. Hess. Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure-radius relations. J. Am. Coll. Cardiol. 7: 455-463, 1986[Abstract].

37.   Wilkinson, L. REGM: a multivariate general linear hypothesis program. Am. Statistician 34: 182, 1980.


AJP Heart Circ Physiol 274(3):H743-H746
0363-6135/98 $5.00 Copyright © 1998 the American Physiological Society



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. H. Lee, J. S. Gounarides, E. S. Roos, and M. S. Wolin
Influence of peroxynitrite on energy metabolism and cardiac function in a rat ischemia-reperfusion model
Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1385 - H1395.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
S. B. Reeder, Y. P. Du, J. A. C. Lima, and D. A. Bluemke
Advanced Cardiac MR Imaging of Ischemic Heart Disease
RadioGraphics, July 1, 2001; 21(4): 1047 - 1074.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Lee, J. Araki, T. Imaoka, M. Maesako, G. Iribe, K. Miyaji, S. Mohri, J. Shimizu, M. Harada, T. Ohe, et al.
Energy-wasteful total Ca2+ handling underlies increased O2 cost of contractility in canine stunned heart
Am J Physiol Heart Circ Physiol, May 1, 2000; 278(5): H1464 - H1472.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schipke, J. D.
Right arrow Articles by Arnold, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schipke, J. D.
Right arrow Articles by Arnold, G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online